The state attorney general approved General Catalyst’s purchase of Summa Health in Akron, but demanded a higher price.

Mitsubishi Research Institute & Astellas collaborate to provide drug-discovery startups in Japan: Tokyo Monday, June 16, 2025, 10:00 Hrs [IST] Mitsubishi Research Institute, Inc.

Mitsubishi Research Institute, Inc. ("MRI") and Astellas Pharma Inc. ("Astellas") today announced that they have agreed on a memorandum of understanding to provide drug-discovery startups in Japan ...

Joint venture will aim to develop a cell ... looking statements about the future performance of Astellas. These statements are based on management's current assumptions and beliefs in light ...

The company will also integrate additional R&D funding and experienced management teams to launch new innovative startups, increasing the number of successful biotech ventures emerging from Japan.

CHICAGO--(BUSINESS WIRE)--Syntax Bio, a preclinical-stage biotechnology company, has launched with backing from Astellas Venture Management LLC and Illumina Ventures. Other investors include ...

"However, when Astellas Venture Management and Montage Ventures approached us, it was clear that they could add significant strategic value. Astellas Pharma and Astellas Institute for Regenerative ...